Sonnet BioTherapeutics I... (SONN)
1.36
0.00 (0.00%)
At close: Apr 25, 2025, 3:59 PM
1.38
1.46%
After-hours: Apr 25, 2025, 04:06 PM EDT
Sonnet BioTherapeutics Revenue
Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending December 31, 2024, Sonnet BioTherapeutics generated $1M in revenue.
Revenue (ttm)
$18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
$1.43K
Employees
13
Market Cap
4.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Sep 30, 2024 | 18.63K | -87.40% |
| Sep 30, 2023 | 147.81K | -57.76% |
| Sep 30, 2022 | 349.94K | -27.64% |
| Sep 30, 2021 | 483.63K | +Infinity% |
| Sep 30, 2020 | 0 | n/a |